• Sustainability
  • DE&I
  • Pandemic
  • Finance
  • Legal
  • Technology
  • Regulatory
  • Global
  • Pricing
  • Strategy
  • R&D/Clinical Trials
  • Opinion
  • Executive Roundtable
  • Sales & Marketing
  • Executive Profiles
  • Leadership
  • Market Access
  • Patient Engagement
  • Supply Chain
  • Industry Trends

ZS Acquires Digital Health Specialist Medullan to Help Accelerate Innovation for Life Sciences


Acquisition is largest in 37-year history of ZS.

Global professional services firm ZS has announced it is acquiring Medullan, a digital medicine strategies and solutions company.

Medullan has developed specialized resources and tools in the digital medicine space, such as the pioneering virtual care and decentralized trial platform, VARA™.

The acquisition is the largest in the history of ZS, a 37-year-old company that now employs over 8,000 professionals across more than 25 offices worldwide. When the transaction is finalized, Medullan’s 80-plus employees will join ZS’s DCH practice.

“Digital health solutions will transform how we experience healthcare, improve lives and reduce costs in the process. While significant progress has been made, there remain many challenges to overcome toward realizing this vision,” said Pete Masloski, principal at ZS and leader of the DCH practice, which Medullan employees will join.

Recent Videos
Related Content